Medtronic
 
 

Activa® Therapy

Overview of Activa
Tremor Control Therapy

Activa Tremor Control Therapy was approved in Canada, Europe and Australia in 1995 and in the United States in 1997 for the treatment of essential and Parkinsonian tremor. It delivers electrical stimulation via a surgically implanted electrode to targeted cells in the left or right ventral intermediate nucleus (VIM) of the thalamus to control tremor symptoms.1,2,3 The stimulation can be adjusted via telemetry to meet each patient's needs.

Activa Tremor Control Therapy

A surgically implanted neurostimulator, similar to a cardiac pacemaker, delivers electrical stimulation to precisely targeted area on the left or right side of the brain to control the signals that cause disabling tremor.

 

References
  1. Bryant, J., et al, The Impact of Thalamic Stimulation of Activities of Daily Living for Essential Tremor. Surg Neurol 2003: 59, 479-485.
  2. Krauss, J. Concepts and Methods in Chronic Thalamic Stimulation for Treatment of Tremor: Technique and Application. Neurosurgery 2001: 48, 535-543.
  3. Tasker, R. Deep Brain Stimulation is Preferable to Thalamotomy for Tremor Suppression. Surg Neurol 1998: 49, 145-154.

Additional Information

  • Register for updates on Medtronic Activa Therapy
  • Visit WeMove.org to learn more about movement disorders education and treatment information
  • Contact Medtronic Activa Physician Services